MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-PB-20-0004365
Market Cap
₹50.64 Cr
AJOONI · NSE
Share Price
₹2.94
0.00% today
Revenue
₹182 Cr
FY 2025-26 · +59.0% YoY
EBITDA
₹6.26 Cr
Margin 3.4%
Net Profit
₹4.32 Cr
FY 2025-26 · +27.4% YoY
P/E (TTM)
12.5x
P/B 0.5x
Authorised capital
₹70 Cr
Registered with MCA
Paid-up capital
₹36.25 Cr
Issued & subscribed
About Ajooni Biotech Limited
Data last updated:
Ajooni Biotech Limited is a public limited company based in Mohali, Punjab, India. It operates in the animal feeds segment of the agriculture sector. It was incorporated on 17 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN L85190PB2010PLC040162. Its GSTIN is 03AAMCA2765P1Z9 (Punjab). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on NSE: AJOONI.
The company has an authorised share capital of ₹70 Cr and a paid-up capital of ₹36.25 Cr. It was formerly known as Ajooni Biotech Private Limited. It is led by directors including Jasjot Singh (Managing Director) and Gursimran Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at D – 118 Industrial Area Phase – 7, Mohali, Punjab, India – 160059.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹182.38 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹4.32 Cr (net margin 2.4%) and EBITDA of ₹6.26 Cr (EBITDA margin 3.4%). The net worth stands at ₹91.19 Cr (up 3.5% YoY). Total assets are valued at ₹109.24 Cr (up 21.1% YoY).
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ajooni Biotech. As per MCA filings, the company has open charges of ₹46.47 Cr and satisfied charges of ₹9.11 Cr on record. Court records list 9 cases involving the company, including 8 filed by the company and 1 filed against it; 2 cases are pending. The company has 137 deals on record (135 market trades, 1 rights issue, 1 ipo); the latest was in September 2026. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 87 overdue payments to 15 micro and small suppliers.
Ajooni Biotech Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PB-20-0004365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ajoonibiotech.com.
Company details
CIN L85190PB2010PLC040162
Registration Number 040162
Incorporation Date 17 February 2010
ROC Chandigarh
Listing Status Listed - Listed on NSE (AJOONI)
Company Status Active
Date of Last AGM 29 July 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-PB-20-0004365
CIN history
Ajooni Biotech has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85190PB2010PLC040162, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85190PB2010PLC040162 | Current |
| U85190PB2010PTC040162 | Previous |
| U85190PB2010PLC040162 | Previous |
| U85190CH2010PTC032031 | Previous |
Key People
Jasjot Singh Managing Director Gursimran Singh Whole-Time Director Simmi Chhabra Director Recognitions & Rankings of Ajooni Biotech
Contact details
Ajooni Biotech Limited's registered office is in Mohali, Punjab. Its website is ajoonibiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 118 Industrial Area Phase – 7, Mohali, Punjab, India – 160059
- IndustryAgriculture, Animal Feeds
To see the full contact details of Ajooni Biotech Limited, buy the company report.
Comprehensive company report
Ajooni Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ajooni Biotech operates one associated brand: Ajooni Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Animal feed and nutrition products are produced and supplied. | ajoonibiotech.com |
Business activity
The main business activity of Ajooni Biotech is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Ajooni Biotech Limited, buy the company report.
Financials of Ajooni Biotech Limited
FY 2025-26 filings availableAjooni Biotech Limited reported revenue of ₹182.38 Cr (up 59% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹182 Cr
+59.0% YoY
EBITDA
₹6.26 Cr
+69.6% YoY
Profit After Tax
₹4.32 Cr
+27.4% YoY
Net Worth
₹91.19 Cr
+3.5% YoY
Total Assets
₹109 Cr
+21.1% YoY
Total Debt
₹17.76 Cr
+815.5% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 182 | 115 | 80.11 | 74.49 | 74.04 | 51.04 | 40.03 |
| Revenue growth | +59.0% | +43.2% | +7.5% | +0.6% | +45.1% | +27.5% | - |
| EBITDA | 6.26 | 3.69 | 2.23 | 2.76 | 3.08 | 1.65 | 1.23 |
| EBITDA margin | +3.4% | +3.2% | +2.8% | +3.7% | +4.2% | +3.2% | +3.1% |
| Profit before tax | 5.74 | 4.34 | 2.99 | 1.57 | 1.47 | 0.51 | 0.47 |
| Net profit | 4.32 | 3.39 | 2.15 | 1.12 | 1.07 | 0.38 | 0.35 |
| Net profit margin | +2.4% | +3.0% | +2.7% | +1.5% | +1.5% | +0.7% | +0.9% |
| EPS (₹) | 0.25 | 0.20 | 0.25 | 0.13 | 1.05 | 0.37 | 0.41 |
| Balance sheet | |||||||
| Total assets | 109 | 90.23 | 45.00 | 46.95 | 21.73 | 22.43 | 20.92 |
| Net worth | 91.19 | 88.08 | 42.71 | 41.67 | 16.39 | 15.66 | 15.90 |
| Total debt | 17.76 | 1.94 | 2.17 | 5.18 | 5.35 | 6.78 | 5.02 |
| Cash & bank | 0.42 | 6.83 | 0.43 | 0.31 | 0.06 | 0.24 | 0.12 |
| Net working capital | 63.35 | 57.19 | 29.81 | 22.89 | 14.64 | 15.83 | 15.35 |
| Cash flow | |||||||
| Cash from operations | (5.73) | (31.97) | 22.91 | (5.58) | 3.68 | 1.16 | (4.38) |
| Cash from investing | (15.77) | 13.55 | 7.64 | (15.82) | (1.90) | (3.41) | 0.47 |
| Cash from financing | 15.09 | 24.83 | (3.57) | 21.66 | (1.97) | 2.37 | 3.30 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.49 | 60.62 | 58.75 | 31.74 | 31.27 | 29.27 | 34.03 | 25.72 |
| Revenue growth (YoY) | +103.0% | +107.1% | +72.6% | +23.4% | +21.9% | - | - | - |
| Other income | 0.27 | 1.30 | 0.32 | 0.15 | 0.65 | 1.34 | 0.39 | 0.31 |
| Total expenses | 61.82 | 59.62 | 55.72 | 30.23 | 30.55 | 28.26 | 33.11 | 24.95 |
| EBITDA | 1.67 | 1.00 | 3.03 | 1.51 | 0.72 | 1.01 | 0.92 | 0.77 |
| EBITDA margin | +2.6% | +1.6% | +5.2% | +4.8% | +2.3% | +3.5% | +2.7% | +3.0% |
| Depreciation | 0.80 | 0.90 | 0.81 | 0.25 | 0.25 | 0.38 | 0.24 | 0.23 |
| Interest | 0.48 | 0.29 | 0.18 | 0.17 | 0.08 | 0.06 | 0.07 | 0.06 |
| Profit before tax | 0.66 | 1.11 | 2.36 | 1.24 | 1.04 | 1.91 | 1.00 | 0.79 |
| Tax | 0.23 | 0.17 | 0.71 | 0.30 | 0.25 | 0.37 | 0.28 | 0.18 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 25 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.49 | 60.62 | 58.75 | 31.74 | 31.27 | 29.27 | 34.03 | 25.72 |
| Revenue growth (YoY) | +103.0% | +107.1% | +72.6% | +23.4% | +21.9% | - | - | - |
| Other income | 0.27 | 1.30 | 0.32 | 0.15 | 0.65 | 1.34 | 0.39 | 0.31 |
| Total expenses | 61.82 | 59.62 | 55.72 | 30.23 | 30.55 | 28.26 | 33.11 | 24.95 |
| EBITDA | 1.67 | 1.00 | 3.03 | 1.51 | 0.72 | 1.01 | 0.92 | 0.77 |
| EBITDA margin | +2.6% | +1.6% | +5.2% | +4.8% | +2.3% | +3.5% | +2.7% | +3.0% |
| Depreciation | 0.80 | 0.90 | 0.81 | 0.25 | 0.25 | 0.38 | 0.24 | 0.23 |
| Interest | 0.48 | 0.29 | 0.18 | 0.17 | 0.08 | 0.06 | 0.07 | 0.06 |
| Profit before tax | 0.66 | 1.11 | 2.36 | 1.24 | 1.04 | 1.91 | 1.00 | 0.79 |
| Tax | 0.23 | 0.17 | 0.71 | 0.30 | 0.25 | 0.37 | 0.28 | 0.18 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 182 | 115 | 80.11 | 74.49 | 74.04 | 51.04 | 40.03 |
| Revenue growth | +59.0% | +43.2% | +7.5% | +0.6% | +45.1% | +27.5% | - |
| Other income | 2.42 | 2.07 | 2.19 | 0.29 | 0.04 | 0.02 | 0.06 |
| Total expenses | 176 | 111 | 77.88 | 71.73 | 70.96 | 49.39 | 38.80 |
| Employee cost | 0.00 | 2.76 | 1.80 | 1.76 | 1.48 | 1.15 | 1.12 |
| EBITDA | 6.26 | 3.69 | 2.23 | 2.76 | 3.08 | 1.65 | 1.23 |
| EBITDA margin | +3.4% | +3.2% | +2.8% | +3.7% | +4.2% | +3.2% | +3.1% |
| Depreciation | 2.21 | 1.09 | 0.87 | 1.00 | 1.11 | 0.58 | 0.49 |
| Interest | 0.73 | 0.33 | 0.56 | 0.48 | 0.54 | 0.58 | 0.33 |
| Profit before tax | 5.74 | 4.34 | 2.99 | 1.57 | 1.47 | 0.51 | 0.47 |
| Tax | 1.42 | 0.95 | 0.84 | 0.45 | 0.41 | 0.13 | 0.14 |
| Net profit | 4.32 | 3.39 | 2.15 | 1.12 | 1.07 | 0.38 | 0.35 |
| Net profit margin | +2.4% | +3.0% | +2.7% | +1.5% | +1.5% | +0.7% | +0.9% |
| EPS (₹) | 0.25 | 0.20 | 0.25 | 0.13 | 1.05 | 0.37 | 0.41 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 34.45 | 34.45 | 17.52 | 17.52 | 10.01 | 10.01 | 8.41 |
| Reserves & surplus | 56.74 | 53.63 | 25.19 | 24.15 | 6.38 | 5.65 | 7.49 |
| Shareholders' funds (net worth) | 91.19 | 88.08 | 42.71 | 41.67 | 16.39 | 15.66 | 15.90 |
| Secured loans | 17.76 | 1.94 | 2.17 | 2.31 | 4.31 | 5.78 | 0.15 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 2.87 | 1.04 | 1.00 | 4.87 |
| Total debt | 17.76 | 1.94 | 2.17 | 5.18 | 5.35 | 6.78 | 5.02 |
| Total liabilities | 109 | 90.23 | 45.00 | 46.95 | 21.73 | 22.43 | 20.92 |
| Assets | |||||||
| Gross block | 34.07 | 17.06 | 14.87 | 9.96 | 8.87 | 6.86 | 3.33 |
| Net block | 26.22 | 11.42 | 10.32 | 6.28 | 6.20 | 5.16 | 2.07 |
| Capital work in progress | 0.00 | 0.29 | 0.92 | 0.26 | 0.00 | 0.00 | 0.00 |
| Investments | 2.45 | 3.49 | 2.14 | 3.74 | 0.70 | 1.15 | 3.08 |
| Inventories | 39.46 | 23.99 | 15.37 | 6.99 | 5.88 | 5.38 | 3.29 |
| Sundry debtors | 17.83 | 16.22 | 12.96 | 20.55 | 13.84 | 13.71 | 12.64 |
| Cash & bank balances | 0.42 | 6.83 | 0.43 | 0.31 | 0.06 | 0.24 | 0.12 |
| Loans & advances | 16.77 | 14.97 | 3.58 | 6.82 | 2.15 | 2.09 | 1.45 |
| Total current assets | 74.48 | 62.01 | 32.34 | 34.67 | 21.93 | 21.42 | 17.50 |
| Total current liabilities | 11.13 | 4.82 | 2.53 | 11.78 | 7.29 | 5.59 | 2.15 |
| Net working capital | 63.35 | 57.19 | 29.81 | 22.89 | 14.64 | 15.83 | 15.35 |
| Total assets | 109 | 90.23 | 45.00 | 46.95 | 21.73 | 22.43 | 20.92 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 6.83 | 0.43 | 0.31 | 0.06 | 0.24 | 0.12 | 0.73 |
| Net cash from operating activities | (5.73) | (31.97) | 22.91 | (5.58) | 3.68 | 1.16 | (4.38) |
| Net cash from investing activities | (15.77) | 13.55 | 7.64 | (15.82) | (1.90) | (3.41) | 0.47 |
| Net cash from financing activities | 15.09 | 24.83 | (3.57) | 21.66 | (1.97) | 2.37 | 3.30 |
| Net change in cash | (6.41) | 6.40 | 26.98 | 0.25 | (0.19) | 0.12 | (0.61) |
| Closing cash | 0.42 | 6.83 | 0.43 | 0.31 | 0.06 | 0.24 | 0.12 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +59.0% | +43.2% | +7.5% | +0.6% | +45.1% | +27.5% | - |
| EBITDA growth | +69.7% | +65.5% | -19.2% | -10.4% | +86.7% | +34.2% | - |
| PBT growth | +32.3% | +45.2% | +90.5% | +6.8% | +188.2% | +8.5% | -4.1% |
| Net income growth | +27.4% | +57.7% | +92.0% | +4.7% | +181.6% | +8.6% | - |
| Revenue CAGR (3Y) | +34.8% | +15.7% | +16.2% | +23.0% | +23.1% | +6.4% | +12.0% |
| EBITDA CAGR (3Y) | +31.4% | +6.2% | +10.6% | +30.9% | +63.9% | +21.1% | +22.5% |
| Profitability & leverage | |||||||
| Net income margin | +2.4% | +3.0% | +2.7% | +1.5% | +1.4% | +0.7% | +0.8% |
| Return on capital employed | - | +6.9% | +7.7% | +6.0% | +9.1% | +5.0% | +4.3% |
| Return on net worth | - | +5.2% | +5.1% | +3.9% | +6.6% | +2.3% | +2.5% |
| Debt / equity | - | 0.03 | 0.09 | 0.18 | 0.38 | 0.37 | 0.35 |
| Long-term debt / equity | - | 0.03 | 0.04 | 0.07 | 0.14 | 0.10 | 0.20 |
| Interest cover | 18.02 | 12.69 | 41.18 | 27.27 | 27.41 | 54.21 | 44.59 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 7.16 | 6.45 | 7.91 | 9.41 | 10.02 | 15.22 |
| Inventory turnover | - | 5.83 | 7.17 | 11.58 | 13.15 | 11.77 | 9.58 |
| Debtors turnover | - | 7.86 | 4.78 | 4.33 | 5.37 | 3.87 | 4.58 |
| EPS (₹) | 0.25 | 0.20 | 0.25 | 0.13 | 1.05 | 0.37 | 0.41 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 5.11 | 4.87 | 4.76 | 16.37 | 15.64 | 18.91 |
To see the full year-wise statements and ratios of Ajooni Biotech Limited, buy the company report.
Board of directors of Ajooni Biotech Limited
Ajooni Biotech has 7 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jasjot Singh Also directs: Healthy Biosciences Limited, Gilbert Kasauli Private Limited | Managing Director | 02 Aug 2017 | 9 Years 2 Months | Current |
| Simmi Chhabra | Director | 02 Aug 2017 | 9 Years 2 Months | Current |
| Gursimran Singh Also directs: Healthy Biosciences Limited | Whole-Time Director | 13 Aug 2020 | 6 Years 2 Months | Current |
| Partek Singh | Director | 30 Jun 2017 | 9 Years 3 Months | Current |
| Ramandeep Singh Also directs: Healthy Biosciences Limited | Director | 02 Aug 2017 | 9 Years 2 Months | Current |
| Imteshwar Singh Bhatia | Director | 02 Aug 2017 | 9 Years 2 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Ajooni Biotech Limited is audited by HARJEET PARVESH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARJEET PARVESH & CO. | FY 2023 | 017437N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 26.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 73.10%.
Sep 2026
QUARTER
26.90% Promoters
73.10% Retail & Others
Promoter holding - history
Now 26.90% · Sep 2026High 26.90% · Dec 2025Low 26.90% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 26.90% | 26.90% | 26.90% | 26.90% |
| Public | 73.10% | 73.10% | 73.10% | 73.10% |
Charges & borrowings
Open charges
₹46.47 Cr
Satisfied charges
₹9.11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Aug 2026 | 101370434 | Hdfc Bank Limited | ₹2.13 Cr | Open | |
| 18 Aug 2026 | 101381688 | Hdfc Bank Limited | ₹3.13 Cr | Open | |
| 18 Jul 2025 | 101136325 | Hdfc Bank Limited | ₹18 Lakh | Open | |
| 04 Sep 2024 | 100986992 | Canara Bank | ₹24 Lakh | Open | |
| 20 Mar 2024 | 100890700 | Canara Bank | ₹38 Lakh | Open |
To see the full charge records of Ajooni Biotech Limited, buy the company report.
Total charge records: 15 View all charges
Deals & funding
Ajooni Biotech Limited has 137 deals on record (135 market trades, 1 rights issue, 1 ipo); the latest was in September 2026.
Total deals
137
Market trades
135
Rights issue
1
IPO
1
Deals on record (5 of 137)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2025 | Market trade | ₹89.8 Lakh | Buyer: Neo Apex Venture LLP Seller: Neo Apex Venture LLP |
| Jul 2024 | Market trade | ₹1.77 Cr | Buyer: 2 individuals Seller: Punjab Biotechnology Park Limited , an individual |
| Jul 2024 | Market trade | ₹4.91 Cr | Buyer: Achintya Securities Limited , 3 individuals Seller: Achintya Securities Limited , 3 individuals |
| Dec 2023 | Market trade | ₹1.05 Cr | Buyer: Virendra Gupta (Huf) Seller: Virendra Gupta (Huf), Pritika Industries Limited |
| Mar 2023 | Market trade | ₹22.8 Lakh | Buyer: an individual Seller: Monifest Capital Private Limited |
To see the full deal history of Ajooni Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ajooni Biotech Limited has 9 court cases on record: 8 filed by Ajooni Biotech, 1 filed against it. 2 cases are pending and 7 are disposed.
Total cases
9
Filed by the company
8
Filed against the company
1
Pending
2
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 0 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Mooofarm Private Limited and Others and 4 others | Pending |
| District court, Mohali, Punjab | Civil miscellaneous application | Filed by the company against an individual | Pending |
| High Court of Punjab and Haryana | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| District court, SAS Nagar, Punjab | Criminal miscellaneous application | Filed by the company against M/S Shri Krishna Trading Company | Disposed |
| District court, Mohali, Punjab | Cheque dishonour complaint | Filed by the company against Ms Maruti Trading Company and 2 others | Disposed |
To see the full case history of Ajooni Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ajooni Biotech Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 87 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Meerut Polypack Private Limited | |||
| an individual supplier | |||
| Tesna Tech Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Ajooni Biotech Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ajooni Biotech Limited has a workforce of 15 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
Employee growth
-16.67%
GST
Ajooni Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAMCA2765P1Z9 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ajooni Biotech Limited, buy the company report.
Recent activity
Ajooni Biotech Limited has 21 board changes on record since 2010: 14 appointments and 7 cessations. The latest: Ishtneet Bhatia was appointed as Director on 03 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.13 Cr with Charge ID 101370434 was registered on 18 Aug 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.13 Cr with Charge ID 101381688 was registered on 18 Aug 2026.
AGM
Ajooni Biotech Limited last Annual general meeting of members was held on 29 Jul 2026 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 40.30 Cr registered on 17 Sep 2021 with Charge ID 100488217 was modified on 21 Jul 2026.
Filing
Ajooni Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101136325 was registered on 18 Jul 2025.
Charges
A charge registered on 03 Sep 2021 via Charge ID 100495978 with Hdfc Bank Limited was fully satisfied on 02 Jun 2025.
Appointed
Ishtneet Bhatia was appointed as Director.
Charges
A charge with Canara Bank amounted to Rs. 0.24 Cr with Charge ID 100986992 was registered on 04 Sep 2024.
Charges
A charge with Canara Bank amounted to Rs. 0.38 Cr with Charge ID 100890700 was registered on 20 Mar 2024.
Charges
A charge registered on 03 May 2019 via Charge ID 100264723 with Canara Bank was fully satisfied on 18 Mar 2024.
Charges
A charge registered on 03 May 2019 via Charge ID 100264727 with Canara Bank was fully satisfied on 18 Mar 2024.
37 earlier events are in the company report.
News
Frequently asked questions
Ajooni Biotech is an active public limited company based in Mohali, Punjab, India. The company works in animal feeds, within the agriculture industry. It was incorporated on 17 February 2010 (16+ years old) and is registered under CIN L85190PB2010PLC040162. Listed on NSE: AJOONI.
Ajooni Biotech reported revenue of ₹182.38 Cr for FY 2025-26 (up 59% YoY) based on standalone financials.
Ajooni Biotech has 7 current directors:
- Jasjot Singh - Managing Director
- Gursimran Singh - Whole-Time Director
- Simmi Chhabra - Director
- Partek Singh - Director
- Ramandeep Singh - Director
- Imteshwar Singh Bhatia - Director
- Ishtneet Bhatia - Director
The latest financial statements of Ajooni Biotech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 July 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Ajooni Biotech is 03AAMCA2765P1Z9, registered in Punjab. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ajooni Biotech is L85190PB2010PLC040162. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Ajooni Biotech is a listed company as per MCA records. Its shares are listed on NSE (symbol: AJOONI).
Ajooni Biotech has 9 court cases on record: 8 filed by the company and 1 filed against it. 2 are pending. Most are in the district courts.
Ajooni Biotech was incorporated on 17 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chandigarh.
Ajooni Biotech has 137 deals on record (135 market trades, 1 rights issue, 1 ipo); the latest was in September 2026.
Ishtneet Bhatia was appointed as Director on 03 Jan 2025. Gurmeet Singh ceased to be CFO on 14 Aug 2021. Gursimran Singh was appointed as Whole-Time Director on 13 Aug 2020. Ajooni Biotech has 21 board changes on record in total.